PD-L1 testing

PD-L1 (programmed death-ligand 1) is a protein some tumor cells use to evade the immune system. Measuring its expression level on tumor tissue helps oncologists gauge — though not guarantee — how likely a checkpoint-inhibitor immunotherapy drug is to be effective, and is one factor among several the tumor board weighs when considering immunotherapy.